Position in BHVN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$468,675
-$1,177,994 QoQ
Shares Held
55,399
-62.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Graham Capital Management, L.P. holds $14,536,772 across 66 Biotechnology names. BHVN ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
4,606 | $870,764 | |
| 2 | TECH |
BIO-TECHNE Corp
|
9,949 | $519,934 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
22,442 | $488,337 | |
| 4 | BHVN |
Biohaven Ltd.
This page
|
55,399 | $468,675 | |
| 5 | NUVL |
Nuvalent, Inc.
|
4,112 | $421,274 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
45,222 | $407,450 | |
| 7 | MNKD |
Mannkind Corp
|
161,189 | $394,913 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
112,831 | $393,780 |
All Filings in BHVN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $468,675 | 55,399 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,646,669 | 145,852 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $504,696 | 33,624 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,683,224 | 119,293 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $219,853 | 6,334 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $214,322 | 8,240 | Shares | Sole | 2023-11-22 | |
| No filing history on record for this holder in this stock. | ||||||